References

medalphabet

Медицинский алфавит

Medical alphabet

2078-56312949-2807

ООО «Альфмед»

medalphabet-182

Research Article

Статьи

Проблема диагностики и лечения идиопатической внутричерепной гипертензии

Problem of diagnosis and treatment of idiopathic intracranial hypertension

Пархоменко

Е. В.

Parkhomenko

E. V.

noemail@neicon.ru

Сорокина

Е. А.

Nartov

S. E.

noemail@neicon.ru

Нартов

С. Э.

Barinov

A. N.

noemail@neicon.ru

Карпов

Д. Ю.

Karpov

D. Yu.

noemail@neicon.ru

Баринов

А. Н.

Sorokina

E. A.

noemail@neicon.ru

ФГБОУ ВО «Алтайский государственный медицинский университет» Минздрава РоссииРоссияAltai State Medical UniversityRussian Federation

ООО «Нейроклиника Карпова»РоссияKarpov’s Neuroclinic CoRussian Federation

ООО «Нейроклиника Карпова»; КГБУЗ «Городская больница № 5»РоссияKarpov’s Neuroclinic Co; City Hospital No. 5Russian Federation

ФГАОУ ВО «Первый Московский государственный медицинский университет имени И. М. Сеченова (Сеченовский университет)» Минздрава РоссииРоссияFirst Moscow State Medical University n.a. I. M. SechenovRussian Federation

2017

16052017

215

Неврология и психиатрия

513

2017

Пархоменко Е.В., Сорокина Е.А., Нартов С.Э., Карпов Д.Ю., Баринов А.Н.

Parkhomenko E.V., Nartov S.E., Barinov A.N., Karpov D.Y., Sorokina E.A.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-alphabet.com/jour/article/view/182

В статье рассматриваются современные представления об этиологии, патогенезе идиопатической внутричерепной гипертензии. Приводятся диагностические критерии, а также обзор наиболее перспективных методов лечения. Представлен клинический случай ИВЧГ у мужчины.

The article considers modern concepts of idiopathic intracranial hypertension, its etiology and pathogenesis. Diagnostic criteria are given, as well as an overview of the most promising methods of treatment. A clinical case of masculine HH is presented.

идиопатическая внутричерепная гипертензияголовные болиотек диска зрительного нерваацетазоламид

idiopathic intracranial hypertensionheadache disorderspapilledematreatmentacetazolamide

References1

Осипова В. В., Азимова Ю. Э., Табеева Г. Р. и др. // Диагностика головных болей в России и странах постсоветского пространства: состояние проблемы и пути ее решения // Анналы клинической и экспериментальной неврологии. - 2012, Т. 6. № 2.- С. 16-21.

Международная классификация головных болей, 2-е издание (полная русскоязычная версия) перевод с английского В. В. Осиповой, Т. Г. Вознесенской. 2003.

Aboul Enein H.A., Abo Khair A. F. Idiopathic intracranial hypertension in children: clinical presenations and management. // Middle East African Journal of Ophthalmology.- 2008, 15 (3).- P. 113-116,

Baker R. S., Baumann R. J., Buncic J. R. Idiopathic intracranial hypertension (pseudomotor cerebri) in pediatric patients. // Pediatric Neurology.- 1989, 5 (1).- P. 5-11.

Smith J. L., Whence pseudotumour cerebri? // J. Clin. Neuroopthalmol.- 1985, 5(1). - P. 55-56.

Mark Portelli, Panagiotis N. Papageorgiou. An update on idiopathic intracranial hypertension. // Acta Neurochirurgica, Published online: 24 December 2016.

Baykan B., Ekizoglu E., Altiokka U. G. An update on the pathophysiology of idiopathic intracranial hypertension alias pseudomotor cerebri.// Agri - 2015, 27 (2). - P. 63-72.

John Chen, M.D., and Michael Wall. Epidemiology and Risk Factors for Idiopathic Intracranial Hypertension. // International Ophthalmology Clinics. - 2014. - 54 (1) P. 1-12.

Asensio-Sánchez V.M., Merino-Angulo J., Martínez-Calvo S., Calvo M. J., Rodríguez R., Epidemiology of pseudotumor cerebri. // Archivos de la Sociedad Espanola de Oftalmologia.- 2007, Apr; 82 (4).- P. 219-221.

Michael Wall, M.D., Mark J. Kupersmith, M.D., Karl D. Kieburtz, M.D., MPH, James J. Corbett, M.D., Steven E. Feldon, M. D. Deborah I. Friedman, M.D., MPH, David M. Katz, M.D., John L. Keltner, M.D., Eleanor B. Schron, Ph.D., and Michael P. McDermott, Ph.D., for the NORDIC Idiopathic Intracranial Hypertension Study Group. The Idiopathic Intracranial Hypertension Treatment Trial. // JAMA Neurol. Author manuscript; available in PMC. - 2015 Jun 1.

Kesler A., Gadoth N., Epidemiology of idiopathic intracranial hypertension in Israel. // Journal of Neuro-Ophthalmology.- 2001, 21 (1).- P. 12-14.

Wall M., George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. // Brain.- 1991, 114 - P. 155-180.

Parunyou Julayanont, Amputch Karukote, Doungporn Ruthirago, Deepa Panikkath, Ragesh Panikkath. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. // Journal of Pain Research.- 2016, 9. - P. 87-99.

Tabassi A., Salmasi A. H., Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. // Neurology.-2005, 64.- P. 1893-1896.

Warner J.E., Larson A.J., Bhosale P., et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. // Journal of Neuro-Ophthalmology. - 2007; 27.- P. 258-262.

Wozniak S. E., Gee L. L., Wachtel M. S., Frezza E.E. Adipose tissue: the new endocrine organ? // Digestive Diseases and Sciences.- 2009, 54.- P. 1847-1856.

Libien J., Blaner W. S. Retinol and retinol-binding protein in cerebrospinal fluid: can vitamin A takethe “idiopathic" out of idiopathic intracranial hypertension? // Journal of Neuro-Ophthalmology.- 2007, 27.- P. 253-257.

Ball A. K., Sinclair A. J., Curnow S.J., Tomlinson J. W., Burdon M. A., Walker E. A., Stewart P. M., Nightingale P. G., Clarke C. E., Rauz S. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? // 2009, 70 (6). - P. 863-869.

Ooi L. Y., Walker B. R., Bodkin P. A., Whittle I. R. Idiopathic intracranial hypertension: can studies ofobesity provide the key to understanding pathogenesis? // British Journal of Neurosurgery. - 2008, 22.- P. 187-194.

Klein A., Stern N., Osher E., Kliper E., Kesler A. Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. // Current Eye Research. - 2013; 38 (9).- P. 972-976.

Hannerz J., Ericson K. The relationship between idiopathic intracranial hypertension and obesity. // Headache. - 2009 Feb, 49(2). - P. 178-84.

Kesler A., Kliper E., Shenkerman G., Stern N. Idiopathic intracranial hypertension is associated with lower body adiposity. // Ophthalmology.- 2010, 117.- P. 169-174.

Glueck C. J., Aregawi D., Goldenberg N., et al. Idiopathic intracranial hypertension, polycys-tic-ovary syndrome, and thrombophilia. // Journal of Laboratory and Clinical Medicine.-2005, 145.- P. 72-82.

Fraser J.A., Bruce B. B., Rucker J., et al. Risk factors for idiopathic intracranial hypertension in men: acase-controlstudy. // Journal of the Neurological Sciences. - 2010, 290.- P. 86-89.

Dhungana S., Waters P., Ismail A., et al. Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. // Journal of Neurology -2010,257. - P. 1211-1212. Journal of Neurology - 2010, 257. - P. 1229-1230. Corrected and republished in: 36.

Kerty E., Heuser K., Indahl U. G., et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. // Acta Ophthalmologica. Sep 13. - 2011.

King L.S., Nielsen S., Agre P. Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat. // Journal of Clinical Investigation - 1996, 97 (10).- P. 2183-2191.

Valerie Biousse, Beau B. Bruce, Nancy J. Newman // Journal of Neurology, Neurosurgery & Psychiatry - 2012 May, 83 (5).- P. 488-194.

Wall M. Idiopathic intracranial hypertension. Journal of Clinical Neurology.- 2010, 28.- P. 593-617.

Bruce B. B., Kedar S., Van Stavern G. P., et al. Idiopathic intracranial hypertension in men. // Neurology - 2009, 72.- P. 304-309.

Wall M., Purvin V. Idiopathic intracranial hypertension in men and the relationship to sleep apnea. // Neurology - 2009, 72.- P. 300-301.

Grace I. Paley, Claire A. Sheldon, Evanette K. Burrows, Marianne R. Chilutti, Grant T. Liu, and Shana E. Mccormack // American Journal of Ophthalmology - 2015 February, 159 (2). - P. 344-52.

Wall M., Kupersmith M. J., Kieburtz K. D., et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. // JAMA Neurology.- 2014, 71 (6).- P. 693-701.

Rigmor Hojland Jensen, Aleksandra Radojicic, Hanne Yri. The diagnosis and management of idiopathic intracranial hypertension and the associated headache. // Therapeutic Advances in Neurological Disorders - 2016 Jul, 9 (4).- P. 317-326.

The International Classification of Headache Disorders, 3rd edition (beta version). Headache Classification Committee of the International Headache Society (IHS). // Cephalalgia.- 2013, 33 (9).- P. 629-808.

Егорова Е. С. Факторы риска развития вторичной атрофии зрительного нерва у пациентов с идиопатической внутричерепной гипертензией. // Вестник ВГМУ. - 2016. - Том 15, № 3.- С. 78-83.

Yri H. M., Fagerlund B., Forchhammer H. B., Jensen R. H. Cognitive function in idiopathic intracranial hypertension: a prospective case-controlstudy. // BMJ Open.- 2014, 4 (4): e004376.

Suzuki H., Takanashi J., Kobayashi K., Nagasawa K., Tashima K., Kohno Y. MR imaging of idiopathic intracranial hypertension. // American Journal of Neuroradiology - 2001, 22 - P. 196-199.

Rajeev Sivasankar, Rochan Pant, Inna K. In-drajit, Raj S. Negi, Samresh Sahu, P. I. Hashim, John D'Souza. Imaging and interventions in idiopathic intracranial hypertension: A pictorial essay. // Indian Journal of Radiology & Imaging - 2015 Oct-Dec, 25 (4).- P. 439-144.

Friedman D. I., Liu G. T., Digre K. B. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and hildren. // Neurology - 2013, 81.- P. 1159-1165.

Liguori C., Romigi A., Albanese M., Marciani M. G., Placidi F., Friedman D., Digre K., Liu G. Revised diagnostic criteriafor the pseudomotor cerebri syndrome in adults and children. // Neurology - 2014, 82 (19).- P. 1752-1753.

Ridha M. A., Saindane A. M., Bruce B. B., et al. MRI indings of elevated intracranial pressure in cerebral venous thrombosis versus idio-pathic intracranial hypertension with transverse sinus stenosis. // Neuroophthalmology. - 2013, 37 (1). - P. 1-6.

Degnan A. J., Levy L. M. Pseudotumor cerebri: Brief review of clinical syndrome and imaging findings. // American Journal of Neuroradiology - 2011; 32 - P. 1986-1993.

Ranganathan S., Lee S. H., Checkver A., et al. Magnetic resonance imaging inding of empty sella in obesity related idiopathic intracranial hypertension is associated with enlarged sella turcica. // Neuroradology.-2013,55 (8).-P. 955-961.

Butros SR, Goncalves LF, Thompson D, Agarwal A, Lee HK. Imaging features of idiopathic intracranial hypertension, including a new inding: widening of the foramen ovale. // Acta Radiol.- 2012; 53 (6).- P. 682-688.

Saindane AM, Bruce BB. Reply to «Enlarged CSF spaces in pseudotumor cerebri». // AJR Am. J. Roentgenol. - 2014, 203 (4).- P. 459.

Bialer OY, Rueda MP, Bruce BB, Newman NJ, Biousse V, Saindane AM. Meningoceles in idiopathic intracranial hypertension. // AJR Am. J. Roentgenol.- 2014, 202 (3).- P. 608-613.

San Millan D, Kohler R. Enlarged CSF spaces in pseudotumor cerebri. // AJR Am. J. Roentgenol.- 2014, 203 (4).- P. 457-458.

Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G. Idiopathicintracranialhypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology. - 2006, 48 (8).- P. 521-527.

Hoffmann J, Huppertz H-J, Schmidt C, et al. Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. // Cephalalgia.- 2013, 33 (13).- P. 1075-1084.

Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. // Neurology - 1996, 46 (1).- P. 198-202.

Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. // Neurology.- 2003, 60 (9).- P. 1418-1424.

Frisen L. Swelling of the optic nerve head: a staging scheme. // J. Neurol. Neurosurg. Psychiatry.- 1982, 45 (1).- P. 13-18.

Carta A, Favilla S, Prato M, Bianchi-Marzoli S, Sadun AA, Mora P. Accuracy of funduscopy to identify true edema versus pseudoedema of the optic disc. // Invest. Ophthalmol. Vis. Sei. - 2012, 53 (і). -P. i-6.

Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V Asymmetric papilledema in idiopathic intracranial hypertension. // J Neuroophthalmol. - 2015, 35 (1).- P. 31-36.

Maxner CE, Freedman MI, Corbett JJ. Asymmetric papilledema and visual loss in pseudo tumour cerebri. II Can. J. Neurol. Sci.- 1987, 14 (4).- P. 593-596.

Singleton J, Dagan A, Edlow JA, Hoffmann B. Real-time optic nerve sheath diameter reduction measured with bedside ultrasound after therapeutic lumbar puncture in a patient with idiopathic intracranial hypertension. // Am. J. Emerg. Med. - 2014; 33 (6).- P. 860.

De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension Pathogenetic implications. // Neurol. Sci. - 2005; 25 (6).- P. 342-344.

M. J. Thurtell and M. Wall, Idiopathic Intracranial Hypertension (Pseudotumor Cerebri): Recognition, Treatment, and Ongoing Management/ Curr. Treat. Options Neurol.- 2013 February, 15 (I).- P. 1-12.

Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. // Acta Neurol. Scand.- 2007/ - 116 (5) P. 322-327.

Paterson R, Depasquale N, Mann S. Pseudotumor cerebri. // Medicine (Baltimore).- 1961, 40. - P. 85-99.

Liu GT, Glaser JS, Schatz NJ: High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. // Am.J. Ophthalmol.- 1994, 118.- P. 88-96.

Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. // Neurology-2007,68 (3).-P. 229-232.

Bidot S, Saindane AM, Pergallo JH, Bruce BB, Newman NJ, Biousse V. Brain imaging in idiopathic intracranial hypertension. // J. Neuroophthalmol - 2015, 35 (4). - P. 400-411.

Newborg B. Pseudotumor cerebri treated by rice reduction diet. // Arch. Intern. Med.- 1974. - May.- 133 (5).- P. 802-807.

Wong R. et al. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. // BMC Ophthalmology 2007, 7: 15.- P. 1-6.

Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). // Ophthalmology - 1998, 105 - P. 2313-2317.

Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D. Bariatric surgery for the treatment of idiopathic intracranial hypertension. // J. Neurosurg.- 2011, 114 (1).- P. 34-39.

Levin AA, Hess D, Hohler AD. Treatment of idiopathic intracranial hypertension with gastric bypass surgery. / Int. J. Neurosci.- 2015, 125 (1).- P. 78-80

Shin RK, Balcer LJ. Idiopathic Intracranial Hypertension. // Curr. Treat. Options Neurol.- 2002 Jul, 4 (4).- P. 297-305.

Piper RJ, Kalyvas AV, Young AMH, Hughes MA, Jamjoom AAB, Fouyas IP. Interventions for idiopathic intracranial hypertension. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD003434.

Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, JacksAS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies MB, Sinclair AJ, Clarke CE. A randomised controlled trial of treatment for idiopathic intracranial hypertension. // J. Neurol. - 2011, 258 (5).- P. 874-881.

Michael Wall et al. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss: The Idiopathic Intracranial Hypertension Treatment Trial // JAMA.- 2014 April 23, 311 (16).- P. 1641-1651.

Rubin RC et al. The production of cerebrospinal fluid in man and its modification by acetazolamide. // J. Neurosurg.- 1966,25. - P. 430-436.

The authors declare that there are no conflicts of interest present.